About Event

Welcome to the 3rd Annual LNP Formulation & Process Development Summit

Powered by latest developments with LNP CRISPR gene editing in the lungs, Bayer and Acuitas uniting to strengthen their Gene Therapy portfolio, new biotech ReNAgade Therapeutics launching with $300m Series A financing, lipid nanoparticles continue to dominate biopharma pipelines in 2024 and beyond as the most successful non-viral delivery vehicle to date. Moving into novel applications from gene therapy and cell therapy, and new disease indications from oncology to rare disease, LNP are equipping scientists with the ability to deliver transformative medicines to patients.

With industry at a critical inflection point as a need to demonstrate clinical advancements for confidence to advance pipelines in 2024, the 3rd LNP Formulation & Process Development Summit will unite again in April with 4 tracks of carefully curated content as the industry’s one-stop-shop to evaluate and optimize LNPs end-to-end development for your given target of interest.

 

This is your unmissable event to hear from 400+ LNP experts on:

Successfully delivering a range of payloads from RNA, CRISPR, Oligonucleotides and beyond

An LNP 101 run down pre-conference to catch you up to speed with this ever-evolving landscape

Explore the ever-changing landscape that is LNP patenting and navigate biopharma partnerships with the IP Patenting & Commercial Day

Lipid Discovery and Screening track: to learn how to best design, synthesize, and perform early formulation activities to enable selecting appropriate payloads and lipids and engineer your particle to control size and charge

Formulation and Delivery track: to enhance your formulation for targeted drug delivery and stability

Analytical Development and Characterization track: uncover and develop and validation of methods to assess quality, identity and purity with accurate characterization

Process Development and Manufacturing track: optimize manufacturing processes before transitioning from clinical scale to commercial scale with GMP compliance

As LNPs continue to take the spotlight in the drug delivery landscape, the 3rd LNP Formulation & Process Development Summit will serve you with key lessons learned, case studies and practical takeaways to fast-track your LNP development. Join us and 400+ LNP experts in April to stay ahead of the curve next on this wave of pioneering LNPs.

Breakdown of Tracks & Benefits

 Pre-Conference LNP 101 Day:

Embark on a transformative journey into the dynamic world of LNPs with our comprehensive program spanning 2023 and 2024. Whether you’re an individual trailblazer, part of forward-thinking company, or getting started in the LNP field, this immersive experience is designed to provide a solid foundation for leveraging LNPs as a powerful delivery vehicle.

Led by esteemed experts at the forefront of LNP development, this event promises to equip you with invaluable insights and practical knowledge. Explore the latest developments and gain a high-level overview of the current landscape, setting the stage for your next steps in the LNP realm.

Track A: Discovery & Screening:

  • Navigating the complex lipid library
  • Seeking the correct model to screen LNPs
  • Understanding relationship between payload and LNP
  • Maintaining control of biodistribution to reach previously undruggable targets
  • Supercharging Automated Screening methods

Track B: Formulation & Delivery:

  • Ensuring extra-hepatic LNP delivery with pinpoint organ targeting
  • Formulating a stable LNP
  • Reducing the occurrence of toxic outcomes upon formulation of LNPs
  • Utilising machine learning & automation to formulate LNPs
  • Analyzing the advanced technology available to formulate next generation LNP drug products

Track C: Characterization & Analytical Development:

  • Maximizing the advanced analytical technology available to drug developers currently
  • Understanding the impact of empty LNPs and characterizing the occurrence of non-encapsulated LNPs
  • Establishing consistent CQAs (Critical Quality Attributes) across LNP development
  • Evaluating the PDI variance across an LNP sample

Track D: Process Development & Manufacturing:

  • Understanding the temperature dynamics to ensure stability of LNPs
  • Ensuring maximal Purity of LNPs throughout process development
  • Limiting the loss of yield during filtration of the LNP drug product  
  • Turbocharging an efficient scale up of LNPs with a smooth transition between phase development
  • Establishing consistency in the tech transfer of LNPs to standardize manufacture

Recommended job titles for this track:

LNP / Lipid Discovery, LNP Screening, Particle Engineering, LNP Chemistry

Recommended job titles for this track:

Pre-Formulation, Delivery, Formulation, Stability, Drug Substance

Recommended job titles for this track:

Analytical Development, Bioanalytical, Characterization, Assay Development

Recommended job titles for this track:

Manufacturing, GMP, CMC, QC, QA, Tech Transfer, MSAT, Process Development, Process Optimization, Drug Product

LNP IP & Commercial Partnerships Post Conference Day:

A unique chance to enhance your understanding of the intellectual property landscape in the LNP field, gaining clarity on collaborative practices while ensuring compliance with legal boundaries.

Additionally, discover strategies to present yourself as a desirable collaborator to prominent biopharmaceutical entities actively seeking productive partnerships with the biotech and academic sectors, allowing for quicker and more efficient clinical advancements in 2024.

Snapshot of Last Year's Event

Screenshot 2023-11-15 085340
Screenshot 2023-11-15 085427
Screenshot 2023-11-15 085456
Screenshot 2023-11-15 085534

Leading Companies Attending

leading companies lnp

More than Just a Meeting

It has been fantastic to see our community grow over the years and continue to advance the development of LNPs.

In addition to the unrivalled scientific content in the form of presentations, panels and roundtable discussions, there will be a variety of extra experiences including:

Poster Sessions

Drinks Receptions

Networking Sessions

Lunch Briefings

Site Tours

What Your Peers Have to Say

“I am looking forward to collaborating with those aiming to develop safe and effective mRNA therapeutics that require repeated administration through this great networking in the 3rd LNP summit”

Jee-Young Park, Executive Director, MediciBio

“I am excited to attend the summit due to the emergence of RNA as a therapeutic modality revolutionizing healthcare. It is exhilarating to be involved in the technological advances in LNP delivery and to hear from innovative companies at the forefront of this fast-evolving field”

Randall Moreadith, President & CEO, Serina Therapeutics